Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ÌìÃÀ´«Ã½ Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
ÌìÃÀ´«Ã½ Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Movement disorder and neurodegeneration in a rat model with myosin 5a mutation
J Alzheimers Dis Parkinsonism
DOI:
George Stoica
J Alzheimers Dis Parkinsonism
DOI:
Ekaterina Rogaeva
J Alzheimers Dis Parkinsonism
DOI:
Soliman Khatib
J Alzheimers Dis Parkinsonism
DOI:
Kazumasa Saigoh
J Alzheimers Dis Parkinsonism
DOI:
Dasiel O Borroto-Escuela
Prevalence of Parkinson’s disease in Egypt: A review of community-based survey
J Alzheimers Dis Parkinsonism
DOI:
Eman M Khedr
J Alzheimers Dis Parkinsonism
DOI:
Ashton Rogers and Amanda McRae
J Alzheimers Dis Parkinsonism
DOI:
Micheal Ugrumov
Use of human embryonic stem cells in the treatment of Parkinson’s disease
J Alzheimers Dis Parkinsonism
DOI:
Geeta Shroff
Evaluation of a rhythmic exercise program for patients with Parkinson’s disease
J Alzheimers Dis Parkinsonism
DOI:
Audun Myskja
Dyskinesia associated with old and new therapies in Parkinson’s disease
J Alzheimers Dis Parkinsonism
DOI:
Sanjay Jaiswal
Thioredoxin-1 suppresses MPP+/MPTP neurotoxicity through enhancing autophagy
J Alzheimers Dis Parkinsonism
DOI:
Jie Bai
J Alzheimers Dis Parkinsonism
DOI:
Dasiel O Borroto-Escuela
J Alzheimers Dis Parkinsonism
DOI:
Kjell Fuxe
New gene therapy approaches for Parkinson’s disease
J Alzheimers Dis Parkinsonism
DOI:
Jose L Lanciego
Make the best use of Scientific Research and information from our 700 + peer reviewed, ÌìÃÀ´«Ã½ Access Journals